Navigation Links
DATATRAK Signs New Client for Rescue Study
Date:11/10/2009

CLEVELAND, Nov. 10 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the award of a Phase III rescue study with a new client, Symbio, LLC. A CRO specializing in dermatology, Symbio will be utilizing DATATRAK eClinical's(TM) hybrid functionality - double data entry and EDC. In an effort to meet the timelines of this fast-track project, Symbio will enter data previously gathered on paper through eClinical's Clinical Data Management component, while new patient data will be captured electronically via eClinical's Electronic Data Capture component.

"Symbio's commitment to being a collaborative resource partner is exemplified by their innovative approach of designing a solution to utilize data previously thought useless. By utilizing DATATRAK eClinical(TM) to collect data from the initial study and data from the rescue study, Symbio will be able to quickly and efficiently provide their client with valuable data for analysis," said Laurence Birch, DATATRAK's Chairman of the Board. "This study exemplifies eClinical's ability to streamline the clinical trial process with the end-to-end clinical data management functionality necessary for conducting EDC and paper studies."

"Symbio is thrilled with the opportunity to collaborate with DATATRAK on this important project. With timing as the priority for our sponsor, DATATRAK will assist us in providing the clinical study report as quickly as possible. eClinical will enable us to provide real time data to the sponsor and streamline the data capture activities from the sites. We are fortunate for this collaboration and look forward to future endeavors," stated Betsey Zbyszynski, Director of Client Services.

About Symbio

Symbio is a full service CRO with a Phase I-IV clinical site that is dedicated to meet and exceed clinical developm
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. DATATRAK International, Inc. to Release 2009 Second Quarter and First-Half Operating Results on August 17, 2009
2. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
3. Quantel Signs a Distribution Agreement With US-based National Biological
4. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
5. Cell Biosciences Signs Agreement to Acquire Alpha Innotech
6. Fauve Intertrade Signs Major Energy Contracts in China
7. SynCo Bio Partners Enters the Japanese Market as it Signs its First Agreement With a Japanese Pharmaceutical Company
8. Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
9. Martek Signs Sole-Source ARA Supply Agreement with Puleva Food S.L.
10. Dendreon Signs Lease for New Manufacturing Facility in Atlanta
11. Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... , Nov. 18, 2014 Cord Blood ... sponsor of the 10th Annual World Stem Cell Summit, the ... stakeholders. The 2014 World Stem Cell Summit will be held ... Antonio, Texas . The World ... development of lifesaving cures and therapies, convening the most prominent ...
(Date:11/18/2014)... Brunswick, NJ (PRWEB) November 18, 2014 ... Data Quality and Transparency Reporting solutions, announced today ... gone live using its Consummate Providerâ„¢ solution in ... Providerâ„¢ is a Global, SaaS based, Data Quality ... organizations and their third party Providers improve their ...
(Date:11/18/2014)... , Nov. 18, 2014 PDL BioPharma, Inc. ... in connection with the acquisition of Durata Therapeutics, Inc. ... connection with the termination of PDL,s credit agreement with ... outstanding of $40 million, accrued interest, and prepayment and ... into a structured financing transaction with Durata in which ...
(Date:11/17/2014)... , Nov. 17, 2014 Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today the formation of a Medical ... to the Company as it advances the Phase ... the treatment of cutaneous T-cell lymphoma (CTCL), a ...
Breaking Biology Technology:Cord Blood Registry Sponsors 2014 World Stem Cell Summit 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 3Alanda Software Completes Successful Implementation of Global Data Quality & Vendor Management Solution for Top Tier Global Biopharmaceutical Company 2PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 4Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 5Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 6
... WAUKESHA, WI. - RedPrairie Corporation , has ... electronic product code (EPC)-compliant radio frequency identification ... in a real-world environment. The RFID Lab is ... tag placement and readability as they prepare for ...
... , University of Wisconsin - Madison spinout company ... from angel investors in Madison and throughout the state ... motion devices and controllers for nanoscale research and manufacturing. ... used to image, measure, and move objects at the ...
... heard UW-Madison professor Raj Veeramani and Menasha Corp. ... importance of innovation in todays economy at the ... Foundation in northeast Wisconsin. , ,The WIN Foundation ... Council, which is the independent, non-profit science and ...
Cached Biology Technology:RedPrairie Builds RFID Lab - Enables Real-World Testing 2WIN Northeast Wisconsin Chapter Launched for Regions Entrepreneurs 2
(Date:11/7/2014)... associate professor, biomedical engineering, in the Grove School ... York, have identified a molecule that could lead ... aggressive forms of breast cancer. , Triple negative ... owing to aggressive proliferation and metastasis and a ... team, discovered the overexpression of intercellular adhesion molecule-1 ...
(Date:11/6/2014)... Except when that predator runs so fast that it essentially ... is the fastest creature on Earth. Some of these half-inch-long ... five miles per hour). The fastest human can do about ... tiger beetle, a person would have to hit 480 miles ... At peak speeds, everything becomes a blur. They can,t gather ...
(Date:11/4/2014)... 2014 – University of Utah engineers developed the first ... fuel produce electricity without needing to ignite the fuel. ... portable electronics, off-grid power and sensors. , A study ... American Chemical Society journal ACS Catalysis . , ... reaction between a fuel and an oxygen-rich source such ...
Breaking Biology News(10 mins):The tiger beetle: Too fast to see 2Jet-fueled electricity at room temperature 2
... is the primary component of nursery container substrates in ... widely used organic material is prompting researchers to investigate ... James E. Altland and Charles Krause of the USDA ... Development Center was designed to determine if ground switchgrass ...
... statistics buried within patient records or detailed in newspaper ... patterns, allowing the discovery of trends that were previously ... use of interactive maps and graphs, combined with word ... events like the spread of Swine flu," said Frank ...
... the Braunschweiger Helmholtz-Zentrums fr Infektionsforschung (Helmholtz Center for ... bacterial communities are able to support the degradation ... collaboration of thirteen partners from nine countries. Research ... today at the HZI. The significance of this ...
Cached Biology News:Switchgrass proves viable as nursery container substrate 2Switchgrass proves viable as nursery container substrate 3Visualization of geographic patterns may predict spread of disease 2Improving the degradation of toxic hydrocarbons 2
Request Info...
... 2'-O-Methyltransferase converts Cap 0 (or Cap 0-like) ... 1 structure has been shown to increase ... 50%. This improvement is seen in Cap ... Capping System as well as those Cap ...
Form: Ready to use Applications: ELISA...
RABBIT ANTI HALOPERIDOL...
Biology Products: